Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | Computed Tomography (CT) | September 29, 2015

High-performance CTs Flood Market

breast density, computed tomography

Caption: High-contrast, high-spatial resolution images of a 44-year-old woman with heterogeneously dense breast are reconstructed from a scan done with the Koning Breast CT scanner. Early this year, the FDA approved the scanner and an associated biopsy bracket. (Image courtesy Koning Corp.)

Providers under pressure to deliver low-dose, routine computed tomography (CT) can pick from the best deals ever.

Want a spectral or dual-energy CT system? You’ve got several choices. Looking for a fast trauma scanner that can do routine cardiac and neuro work? You can pick up a 64 or 128 slicer at mid-tier prices. Specialty systems are popping up, as well. One dedicated to breast imaging, approved for sale in the U.S., will be on display at this year’s Radiological Society of North America (RSNA) conference. Another is in the works for orthopedics. They’re joining the ranks of portable systems, which have been around for awhile, but recently came under new ownership.  

This may be good news for buyers, at least in the short term. But industry analyst Michael Silver believes major vendors’ portfolios are bloated. “I think there are too many CT offerings,” said Silver, a senior fellow at SG2, a consulting firm that advises hospitals on equipment purchases and services.

Silver blames the global market for the glut. “Some vendors say we need one kind of offering for the Chinese market; another one for the Japanese; this for the Indian; one for the European; multiple ones for the U.S.,” he said.

Selling and supporting multiple platforms adds cost, according to Silver. “Ultimately that plays against the competitiveness of vendors in the long-term,” he said. 

Meanwhile the ranks of CT vendors are expanding. Several new entrants may be at McCormick Place in Chicago in a couple months. One sure to be there is the Koning Breast CT, which the FDA approved for sale in the U.S. after extensive clinical testing as part of the Administration’s PMA (Premarket Approval) process. In announcing the approval, Koning Corporation highlighted the unique product’s ability to generate 3-D images of the entire breast without compression.

The 3-D images promise diagnostic advantages similar to those of tomosynthesis, while the lack of compression is sure to appeal to women who have long complained about discomfort during conventional mammography, which routinely uses a paddle to flatten the breast.

Not yet ready for prime time is a cone beam CT scanner that Carestream Health is grooming for orthopedic and sports medicine specialists in hospitals and clinics. A conceptual scale model of the scanner appeared in September at the British Orthopaedic Association (BOA) Annual Congress. Carestream is now optimizing the system for low-dose imaging of patient extremities, particularly knees, legs and feet. Its development is part of an initiative by the company to address what it says are unmet needs in orthopedics.  

Sure to appear at this year’s RSNA are mobile CT offerings obtained by Samsung in its acquisition of Neurologica in early 2013. The 32-slice BodyTom and 8-slice CereTom are being used in emergency departments, ICUs and neurosurgical ORs, according to the company.

Value CTs from Asia are exemplified in the portfolio of Japanese vendors, such as Hitachi, Toshiba and Shimadzu, as well as Chinese vendors, notably Neusoft. Recently Chinese upstart United Imaging Healthcare (UIH) appeared on the radar of major vendors for the threat it poses to multinational brands.

The company has not registered to exhibit at this year’s RSNA. But in 2013 it opened an office in Houston, “as a first step in UIH’s global talent strategy.” Its publicly stated goal is to “recruit top medical professionals in the surrounding regions, and to promote UIH’s R&D capabilities to a new level.”

An industry intelligence report said the Chinese company’s current crop of CTs (and digital radiography (DR) systems) is as good as those of global competitors. These products and services are likely to meet with the satisfaction of “even premium customers,” according to the report. 

Related Content

Right mediolateral oblique (MLO) mammograms for different women with the same breast thickness but varying breast density.

Right mediolateral oblique (MLO) mammograms for different women with the same breast thickness but varying breast density.

News | Breast Imaging | July 30, 2021
July 30, 2021 — Volpara Health, a global health technology software leader providing an integrated breast care platfo
Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of personalized breast care, has signed an agreement with Invitae Corporation, a leader in medical genetics, to bring Invitae's genetic testing services to Volpara's customers in the United States. 
News | Breast Imaging | July 29, 2021
July 29, 2021 — Volpara Health, a global health technology software leader providing an...
According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely to result in adverse outcome

Normal right mediolateral oblique (A) and craniocarudal (B) view screening mammograms demonstrate density C breasts. Coronal (C), transverse (D), and reconstructed lateral (E) views from supplemental automatic breast ultrasound (ABUS) demonstrates 7 mm circumscribed slightly hypoechoic circumscribed lesion at 11 o’clock position in right breast. Lesion was classified as BI-RADS 3. Patient has undergone yearly mammograms for 4 years following the ABUS examination with no breast cancer diagnosis.

News | Breast Imaging | July 16, 2021
July 16, 2021 —...
Volpara now holds 98 granted patents across 27 countries
News | Breast Imaging | July 16, 2021
July 16, 2021 — Volpara has recently been granted another patent by the...
The prevalence of genetic mutations associated with breast cancer in Black and white women is the same, according to a new JAMA Oncology study of nearly 30,000 patients led by researchers in the Basser Center for BRCA at the Abramson Cancer Center.

Getty Images

News | Women's Health | June 15, 2021
June 15, 2021 — The prevalence of genetic mutations associated with breast cancer in Black and white women is the sam
Kathryn A. Gold, M.D., associate clinical professor at University of California San Diego School of Medicine, presented data showing an increase in people diagnosed with advanced stage breast cancer in 2020 and 2021, compared to 2019.

Kathryn A. Gold, M.D., associate clinical professor at University of California San Diego School of Medicine, presented data showing an increase in people diagnosed with advanced stage breast cancer in 2020 and 2021, compared to 2019.

News | Breast Imaging | June 08, 2021
June 8, 2021 — Reporting at the 2021 annual meeting of the American S...
Medical researchers at Flinders University have established a new link between high body mass index (BMI) and breast cancer survival rates — with clinical data revealing worse outcomes for early breast cancer (EBC) patients and improved survival rates in advanced breast cancer (ABC).

Getty Images

News | Women's Health | May 13, 2021
May 13, 2021 — Medical researchers at Flinders University
News | Artificial Intelligence | May 11, 2021
May 11, 2021 — Whiterabbit, an AI technology company focused on early...